Literature DB >> 30232191

Natural Secretory Immunoglobulins Promote Enteric Viral Infections.

Holly Turula1,2, Juliana Bragazzi Cunha1, Bernardo A Mainou3,4, Sadeesh K Ramakrishnan5, Carol A Wilke6, Mariam B Gonzalez-Hernandez1,2, Alexandra Pry1, Julianne Fava1, Christine M Bassis7, Jacob Edelman1, Yatrik M Shah5, Blaise Corthesy8, Bethany B Moore1,2,6, Christiane E Wobus9,2.   

Abstract

Noroviruses are enteric pathogens causing significant morbidity, mortality, and economic losses worldwide. Secretory immunoglobulins (sIg) are a first line of mucosal defense against enteric pathogens. They are secreted into the intestinal lumen via the polymeric immunoglobulin receptor (pIgR), where they bind to antigens. However, whether natural sIg protect against norovirus infection remains unknown. To determine if natural sIg alter murine norovirus (MNV) pathogenesis, we infected pIgR knockout (KO) mice, which lack sIg in mucosal secretions. Acute MNV infection was significantly reduced in pIgR KO mice compared to controls, despite increased MNV target cells in the Peyer's patch. Natural sIg did not alter MNV binding to the follicle-associated epithelium (FAE) or crossing of the FAE into the lymphoid follicle. Instead, naive pIgR KO mice had enhanced levels of the antiviral inflammatory molecules interferon gamma (IFN-γ) and inducible nitric oxide synthase (iNOS) in the ileum compared to controls. Strikingly, depletion of the intestinal microbiota in pIgR KO and control mice resulted in comparable IFN-γ and iNOS levels, as well as MNV infectious titers. IFN-γ treatment of wild-type (WT) mice and neutralization of IFN-γ in pIgR KO mice modulated MNV titers, implicating the antiviral cytokine in the phenotype. Reduced gastrointestinal infection in pIgR KO mice was also observed with another enteric virus, reovirus. Collectively, our findings suggest that natural sIg are not protective during enteric virus infection, but rather, that sIg promote enteric viral infection through alterations in microbial immune responses.IMPORTANCE Enteric virus, such as norovirus, infections cause significant morbidity and mortality worldwide. However, direct antiviral infection prevention strategies are limited. Blocking host entry and initiation of infection provides an established avenue for intervention. Here, we investigated the role of the polymeric immunoglobulin receptor (pIgR)-secretory immunoglobulin (sIg) cycle during enteric virus infections. The innate immune functions of sIg (agglutination, immune exclusion, neutralization, and expulsion) were not required during control of acute murine norovirus (MNV) infection. Instead, lack of pIgR resulted in increased IFN-γ levels, which contributed to reduced MNV titers. Another enteric virus, reovirus, also showed decreased infection in pIgR KO mice. Collectively, our data point to a model in which sIg-mediated microbial sensing promotes norovirus and reovirus infection. These data provide the first evidence of the proviral role of natural sIg during enteric virus infections and provide another example of how intestinal bacterial communities indirectly influence MNV pathogenesis.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  RNA virus; enteric viruses; gastrointestinal infection; pathogenesis

Mesh:

Substances:

Year:  2018        PMID: 30232191      PMCID: PMC6232472          DOI: 10.1128/JVI.00826-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  91 in total

1.  Latent infection by γherpesvirus stimulates profibrotic mediator release from multiple cell types.

Authors:  Joshua S Stoolman; Kevin M Vannella; Stephanie M Coomes; Carol A Wilke; Thomas H Sisson; Galen B Toews; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-29       Impact factor: 5.464

Review 2.  The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces.

Authors:  Charlotte S Kaetzel
Journal:  Immunol Rev       Date:  2005-08       Impact factor: 12.988

3.  Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform.

Authors:  James J Kozich; Sarah L Westcott; Nielson T Baxter; Sarah K Highlander; Patrick D Schloss
Journal:  Appl Environ Microbiol       Date:  2013-06-21       Impact factor: 4.792

4.  Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing).

Authors:  H W Virgin; R Bassel-Duby; B N Fields; K L Tyler
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  Inefficient antigen presentation via the IgA Fc receptor (FcalphaRI) on dendritic cells.

Authors:  Marielle A Otten; Irene Groenveld; Jan G J van de Winkel; Marjolein van Egmond
Journal:  Immunobiology       Date:  2006-07-05       Impact factor: 3.144

6.  Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor.

Authors:  Nicholas J Mantis; Marsha C Cheung; Koteswara R Chintalacharuvu; Jacques Rey; Blaise Corthésy; Marian R Neutra
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

7.  Murine norovirus transcytosis across an in vitro polarized murine intestinal epithelial monolayer is mediated by M-like cells.

Authors:  Mariam B Gonzalez-Hernandez; Thomas Liu; Luz P Blanco; Heather Auble; Hilary C Payne; Christiane E Wobus
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

Review 8.  Viruses in Rodent Colonies: Lessons Learned from Murine Noroviruses.

Authors:  Stephanie M Karst; Christiane E Wobus
Journal:  Annu Rev Virol       Date:  2015-07-02       Impact factor: 10.431

9.  Norovirus Escape from Broadly Neutralizing Antibodies Is Limited to Allostery-Like Mechanisms.

Authors:  Abimbola O Kolawole; Hong Q Smith; Sophia A Svoboda; Madeline S Lewis; Michael B Sherman; Gillian C Lynch; B Montgomery Pettitt; Thomas J Smith; Christiane E Wobus
Journal:  mSphere       Date:  2017-10-18       Impact factor: 4.389

10.  A high-throughput DNA sequence aligner for microbial ecology studies.

Authors:  Patrick D Schloss
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more
  8 in total

1.  Natural Secretory Immunoglobulins Promote Enteric Viral Infections.

Authors:  Holly Turula; Juliana Bragazzi Cunha; Bernardo A Mainou; Sadeesh K Ramakrishnan; Carol A Wilke; Mariam B Gonzalez-Hernandez; Alexandra Pry; Julianne Fava; Christine M Bassis; Jacob Edelman; Yatrik M Shah; Blaise Corthesy; Bethany B Moore; Christiane E Wobus
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

Review 2.  Interactions between noroviruses, the host, and the microbiota.

Authors:  Forrest C Walker; Megan T Baldridge
Journal:  Curr Opin Virol       Date:  2019-05-13       Impact factor: 7.090

Review 3.  IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.

Authors:  Annelot Breedveld; Marjolein van Egmond
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

Review 4.  The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics.

Authors:  Jessica M van Loben Sels; Kim Y Green
Journal:  Viruses       Date:  2019-05-10       Impact factor: 5.048

Review 5.  Diverse Mechanisms Underlie Enhancement of Enteric Viruses by the Mammalian Intestinal Microbiota.

Authors:  Alexa N Roth; Katrina R Grau; Stephanie M Karst
Journal:  Viruses       Date:  2019-08-17       Impact factor: 5.048

Review 6.  Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis.

Authors:  Hao Wei; Ji-Yang Wang
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

Review 7.  Norovirus: Facts and Reflections from Past, Present, and Future.

Authors:  Yalda Lucero; David O Matson; Shai Ashkenazi; Sergio George; Miguel O'Ryan
Journal:  Viruses       Date:  2021-11-30       Impact factor: 5.048

Review 8.  Virus interactions with bacteria: Partners in the infectious dance.

Authors:  Ursula Neu; Bernardo A Mainou
Journal:  PLoS Pathog       Date:  2020-02-11       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.